1. Home
  2. BHR vs ACOG Comparison

BHR vs ACOG Comparison

Compare BHR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHR

Braemar Hotels & Resorts Inc.

N/A

Current Price

$2.16

Market Cap

159.3M

Sector

Real Estate

ML Signal

N/A

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$8.13

Market Cap

185.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHR
ACOG
Founded
2013
2000
Country
United States
Canada
Employees
N/A
71
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
185.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BHR
ACOG
Price
$2.16
$8.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
702.4K
92.2K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
8.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.88
$4.50
52 Week High
$3.19
$10.14

Technical Indicators

Market Signals
Indicator
BHR
ACOG
Relative Strength Index (RSI) 52.16 62.00
Support Level $1.93 $5.17
Resistance Level $2.61 $8.80
Average True Range (ATR) 0.09 0.54
MACD 0.02 -0.07
Stochastic Oscillator 74.07 57.78

Price Performance

Historical Comparison
BHR
ACOG

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: